Perioperative Prophylactic Antibiotics in 1,250 Orbital Surgeries.


Journal

Ophthalmic plastic and reconstructive surgery
ISSN: 1537-2677
Titre abrégé: Ophthalmic Plast Reconstr Surg
Pays: United States
ID NLM: 8508431

Informations de publication

Date de publication:
Historique:
pubmed: 10 1 2020
medline: 19 3 2021
entrez: 10 1 2020
Statut: ppublish

Résumé

Intravenous antibiotic prophylaxis is used for many clean-contaminated surgeries or clean surgeries with an implant, but its value for clean orbital surgery has not been determined. This study investigated infection risks and adverse effects related to antibiotics in patients undergoing orbital surgery. A prospective, nonrandomized comparative case series of all patients undergoing orbital surgery with participating surgeons between October 1, 2013, and March 1, 2015. Types of surgery, antibiotic regimens, corticosteroid use, antibiotic side effects, and surgical site infections (SSIs) were entered into an electronic database and subsequently analyzed. Cases in which patients received postoperative oral antibiotics were analyzed separately. Of 1,250 consecutive orbital surgeries, 1,225 met inclusion criteria. A total of 1208 patients were included in the primary analysis: 603 received no antibiotic prophylaxis (group A), and 605 received a single dose of intravenous antibiotic (group B). Five patients (0.42%) developed an SSI, 3 in group A and 2 in group B. The difference in SSI rates was not statistically significant between the 2 groups (p = 0.66). Antibiotic prophylaxis, alloplastic implants, paranasal sinus entry, and corticosteroid use were not associated with differences in SSI rates. All SSIs resolved on a single course of oral antibiotics; an implant was removed in 1 case. There were no complications associated with a single dose of intravenous prophylaxis. However, 12% of 17 patients (group C) who received 1 week of oral postoperative prophylactic antibiotics developed antibiotic-related complications (diarrhea, renal injury), yielding a number needed to harm of 8.5. In this large series, antibiotic prophylaxis does not appear to have reduced the already low incidence of SSI following orbital surgery. Given the detriments of systemic antibiotics, the rarity of infections related to orbital surgery, and the efficacy of treating such infections should they occur, patients undergoing orbital surgery should be educated to the early symptoms of postoperative infection and followed closely, but do not routinely require perioperative antibiotics.

Identifiants

pubmed: 31917766
doi: 10.1097/IOP.0000000000001565
pii: 00002341-202007000-00011
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

385-389

Références

Blaser MJ. Missing Microbes. 2014.New York: Holt and Co.
Radda TM, Grasl MM, Gnad HD. Perioperative prevention of infection in ophthalmic surgery. Antibiot Chemother (1971) 1985;33:184–197.
Berríos-Torres SI, Umscheid CA, Bratzler DW, et al.; Healthcare Infection Control Practices Advisory Committee. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg 2017;152:784–791.
Bratzler DW, Dellinger EP, Olsen KM, et al.; American Society of Health-System Pharmacists; Infectious Disease Society of America; Surgical Infection Society; Society for Healthcare Epidemiology of America. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013;70:195–283.
Fay A, Nallasamy N, Nallassamy N, et al.; New England Oculoplastics Society Study Group. Prophylactic postoperative antibiotics for enucleation and evisceration. Ophthalmic Plast Reconstr Surg 2013;29:281–285.
World Health Organization. Global guidelines for the prevention of surgical site infection. http://www.who.int/gpsc/ssi-guidelines/en/. Accessed November 2017
Pariseau B, Fox B, Dutton J. Prophylactic antibiotics for enucleation and evisceration: a retrospective study and systematic literature review. Ophthalmic Plast Reconstr Surg 2018;34:49–54.
Fay A, Nallasamy N, Bernardini F, et al. Multinational comparison of prophylactic antibiotic use for eyelid surgery. JAMA Ophthalmol. 2015;133:778–784.
Centers for Disease Control and Prevention (CDC). Surgical Site Infection (SSI) Event. January 2017 update. http://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf. Accessed November 2017
European Centre for Disease Prevention and Control (ECDC). Surveillance of surgical site infections in European hospitals – HAISSI protocol. Protocol version 1.02. 2012. Stockholm: ECDC, http://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/120215_TED_SSI_protocol.pdf.
Beceiro A, Tomás M, Bou G. Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?. Clin Microbiol Rev 2013; 26:185–230.
Azad MB, Bridgman SL, Becker AB, et al. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int J Obes (Lond) 2014;38:1290–1298.
Russell SL, Gold MJ, Reynolds LA, et al. Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases. J Allergy Clin Immunol 2015;135:100–109.
Stefka AT, Feehley T, Tripathi P, et al. Commensal bacteria protect against food allergen sensitization. Proc Natl Acad Sci U S A 2014;111:13145–13150.
Theodorou V, Ait Belgnaoui A, Agostini S, et al. Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome. Gut Microbes 2014;5:430–436.
Garlock JH, Seley GP. The use of sulfanilamide in surgery of the colon and rectum: preliminary report. Surgery 1939;5:787–790.
Miles AA, Miles EM, Burke J. The value and duration of defence reactions of the skin to the primary lodgement of bacteria. Br J Exp Pathol 1957;38:79–96.
Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961;50:161–168.
Garner JS. CDC guideline for prevention of surgical wound infections, 1985. Supersedes guideline for prevention of surgical wound infections published in 1982. (Originally published in November 1985). Revised. Infect Control 1986;7:193–200.
Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital infection control practices advisory committee. Infect Control Hosp Epidemiol 1999;20:250–78; quiz 279–80.
Balch A, Wendelboe AM, Vesely SK, et al. Antibiotic prophylaxis for surgical site infections as a risk factor for infection with Clostridium difficile. PLoS One 2017;12:e0179117.

Auteurs

Aaron Fay (A)

Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.

Nambi Nallasamy (N)

Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami.

Richard C Allen (RC)

Department of Ophthalmology and Visual Sciences, University of Iowa Hospitals and Clinics, Iowa City, Iowa.

Francesco P Bernardini (FP)

Oculoplastica Bernardini, Genova, Italy.

Jurij R Bilyk (JR)

Oculoplastics and Orbital Surgery, Wills Eye Hospital, Philadelphia, Pennsylvania.

Kimberly Cockerham (K)

Department of Ophthalmology, Stanford University.

Antonio Augusto Cruz (AA)

Department of Ophthalmology, School of Medicine of Ribeirão Preto, University of São Paulo, Brazil.

Martin Devoto (M)

Consultores Oftalmológicos, Buenos Aires, Argentina.

Peter J Dolman (PJ)

Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia.

Jonathan J Dutton (JJ)

Department of Ophthalmology, University of North Carolina, Chapel Hill, North Carolina.

David R Jordan (DR)

University of Ottawa Eye Institute, Ottawa Hospital and Children's Hospital of Eastern Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario.

Robert Kersten (R)

Department of Ophthalmology, University of California San Francisco, San Francisco, California.

Yoon-Duck Kim (YD)

Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Mark J Lucarelli (MJ)

Department of Ophthalmology, University of Wisconsin, Madison, Wisconsin.

Alan A McNab (AA)

Royal Victorian Eye and Ear Hospital, Melbourne, Australia.

Ilse Mombaerts (I)

Department of Ophthalmology, University Hospitals Leuven, Leuven, Belgium.

Maarten Mourits (M)

Academisch Ziekenhuis Utrecht, Utrecht, The Netherlands.

Jeffrey Nerad (J)

Department of Ophthalmology, University of Cincinnati, Cincinnati, Ohio.

Julian D Perry (JD)

Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio.

Geoffrey Rose (G)

Moorfields Eye Hospital, London, England and NIHR Biomedical Research Centre, UCL Institute of Ophthalmology, London, England.

Peerooz Saeed (P)

Orbital center, Academic medical center, University of Amsterdam Amsterdam, The Netherlands.

Lay Leng Seah (LL)

Singapore National Eye Centre, National University of Singapore, Singapore.

Dinesh Selva (D)

Discipline of Ophthalmology & Visual Sciences, University of Adelaide, Adelaide, Australia.

Jennifer Sivak-Callcott (J)

Department of Ophthalmology, West Virginia University, Morgantown, West Virginia.

Diego Strianese (D)

King Khaled Eye Hospital, Riyadh, Saudi Arabia.
Department of Ophthalmology, University of Naples Federico II, Naples, Italy.

David H Verity (DH)

Moorfields Eye Hospital, London, England.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH